MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer

Recent studies have shown that the mediator complex (MED) plays a vital role in tumorigenesis and development, but the role of MED16 (mediator complex subunit 16) in breast cancer (BC) is not clear. Increasing evidence has shown that the mTOR pathway is important for tumour progression and therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Han, Li, Kang, Shu, Dan, Shen, Meiying, Tan, Zhaofu, Zhang, Wenjie, Pu, Dongyao, Tan, Wenhao, Tang, Zhenrong, Jin, Aishun, Liu, Shengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604881/
https://www.ncbi.nlm.nih.gov/pubmed/36294896
http://dx.doi.org/10.3390/life12101461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604881/
https://www.ncbi.nlm.nih.gov/pubmed/36294896
http://dx.doi.org/10.3390/life12101461

Ejemplares similares